RCKT Rocket Pharmaceuticals

添加自選

8.530
-0.060-0.70%

交易中 03/11 09:30 (美東)

9.10億總市值-3.12市盈率TTM

關於Rocket Pharmaceuticals公司

Rocket Pharmaceuticals Inc 是一家後期生物製藥公司。公司專注於開發罕見和毀滅性兒科疾病的基因療法。公司的渠道產品包括用於Danaon病的RP-A501、用於範可尼貧血的RP-L102、用於白細胞粘附的RP-L201、用於丙酮酸激酶缺乏症的RP-L301和用於嬰兒惡性骨質疏鬆症的RP-L401。

公司介紹

公司代碼RCKT

公司名稱Rocket Pharmaceuticals

上市日期2015/02/18

發行價格6.00

成立日期1999

CEODr. Gaurav Shah, M.D.

所屬市場納斯達克

員工數量299

年結日12-31

公司地址9 Cedarbrook Drive

城市Cranbury

省份新澤西

國家美國

郵編08512

電話1-609-659-8001

網址http://www.rocketpharma.com

董事高管

姓名
職務
年薪

Dr. Gaurav Shah, M.D.
Director and Chief Executive Officer
801.36萬

Aaron Ondrey
Chief Financial Officer
--

Martin Wilson, J.D.
Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
--

Jonathan Schwartz, M.D.
Chief Medical Officer and Chief Gene Therapy Officer
315.78萬

Raj Prabhakar
Chief Business Officer and Senior Vice President
--

Dr. Kinnari Patel, M.B.A.,Pharm.D.
President, Chief Operating Officer and Head of R&D
484.61萬

Mayo Pujols
Chief Technical Officer and Executive Vice President
437.77萬

John Militello, C.P.A.
Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
152.76萬

Dr. Roderick Wong, M.D.
Chairman of the Board
41.00萬

Piratip Pratuwan
Director
--

Dr. Mikael Dolsten, M.D.
Director
--

Carsten Boess
Independent Director
42.75萬

Dr. Fady Ibraham Malik, M.D.,PhD
Independent Director
40.00萬

Dr. Elisabeth Bjork, M.D.,PhD
Independent Director
41.00萬

David P. Southwell
Independent Director
40.00萬

Pedro P. Granadillo
Independent Director
43.00萬

Dr. Gotham Makker, M.D.
Independent Director
40.00萬

Robert Keith Woods
Independent Director
56.87萬

RCKT Rocket Pharmaceuticals

關於Rocket Pharmaceuticals公司

公司介紹

董事高管

市場投資機會